Table 2.
Predictor | Statin | Beta—blocker | ACEI /ARB | All of statin, beta—blocker, and ACEI/ARB |
---|---|---|---|---|
Year of discharge (per year) | 1.08 (1.06–1.10) | 1.03 (1.02–1.05) | 0.99 (0.98–1.01) | 1.09 (1.06–1.12) |
Demographics | ||||
Age (per year) | 1.00 (1.00–1.01) | 1.00 (1.00–1.01) | 1.00 (1.00–1.01) | 1.00 (0.99–1.01) |
Male | 1.07 (0.97–1.17) | 0.88 (0.82–0.94) | 0.93 (0.86–1.00) | 0.85 (0.74–0.98) |
White race | 1.79 (1.56–2.05) | 1.54 (1.40–1.70) | 1.46 (1.32–1.61) | 1.74 (1.43–2.11) |
Nursing home residence* | 1.05 (0.86–1.27) | 1.22 (1.08–1.38) | 1.30 (1.15–1.47) | 1.41 (1.06–1.87) |
Co—morbid conditions | ||||
Congestive heart failure | 0.99 (0.91–1.08) | 1.00 (0.94–1.07) | 1.25 (1.16–1.34) | 1.02 (0.90–1.16) |
Cerebrovascular disease | 1.04 (0.95–1.13) | 0.97 (0.97–1.04) | 1.02 (0.96–1.09) | 0.99 (0.87–1.12) |
Peripheral vascular disease | 1.06 (0.97–1.17) | 1.04 (0.97–1.11) | 0.98 (0.92–1.06) | 1.05 (0.92–1.19) |
Hypertension | 1.14 (1.03–1.26) | 1.15 (1.07–1.24) | 1.08 (1.00–1.17) | 1.20 (1.02–1.40) |
Diabetes | 1.00 (0.92–1.08) | 0.97 (0.92–1.03) | 1.05 (0.98–1.12) | 1.05 (0.93–1.19) |
Chronic obstructive pulmonary disease | 0.82 (0.75–0.89) | 0.83 (0.91–1.04) | 0.87 (0.81–0.93) | 0.76 (0.67–0.86) |
Chronic kidney disease | 1.13 (1.02–1.25) | 1.05 (0.98–1.14) | 0.80 (0.73–0.86) | 0.89 (0.76–1.03) |
Procedures on index hospitalization | ||||
Angioplasty or stent insertion | 1.03 (0.94–1.13) | 1.09 (1.01–1.17) | 0.89 (0.82–0.97) | 1.05 (0.92–1.19) |
CABG | 0.79 (0.69–0.90) | 0.99 (0.89–1.10) | 0.84 (0.75–0.94) | 0.84 (0.69–1.03) |
Health system use | ||||
Concurrent drugs (per drug) | 1.01 (1.00–1.02) | 1.01 (1.00–1.01) | 1.01 (1.00–1.01) | 1.00 (0.99–1.01) |
Hospitalizations in prior year (per day) | 0.99 (0.99–1.00) | 0.99 (0.99–1.00) | 0.99 (0.99–1.00) | 0.99 (0.99–1.00) |
Number of outpatient visits in prior year | 1.00 (0.99–1.00) | 0.99 (0.99–1.00) | 0.99 (0.99–1.00) | 1.00 (0.99–1.01) |
During the year prior to the index MI.